Why the study?
Does an elevated stress hyperglycemia ratio (SHR) predict worse long-term outcomes in patients with acute coronary syndrome?
Does an elevated stress hyperglycemia ratio (SHR) predict worse long-term outcomes in patients with acute coronary syndrome?
Elevated stress hyperglycemia ratio serves as a potential biomarker for risk stratification after acute coronary syndrome, predicting worse long-term outcomes regardless of baseline diabetic status.
SHR may aid post-ACS risk stratification irrespective of diabetes; leaves open need for trials to test therapeutic targeting.
Elevated SHR was independently associated with a higher risk of long-term outcomes irrespective of diabetic status, suggesting that SHR was a potential biomarker for risk stratification after ACS.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: